Prem Ramkumar
Orthopaedic Surgery · Downey, CANPI 1255794889
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.6%), grants and education — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Stryker at 46.3% of the total. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 145 payments — averaging $513.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$35K
- Arthrex$18K
- Smith+Nephew$14K
- Globus Medical$7K
- Pacira Pharmaceuticals Incorporated$560
- Motive Health, Inc.$78
- plus $116 from 3 others
Across 1 payment — averaging $5425.28 each. An ownership or investment interest held by the physician or an immediate family member.
- Overture Orthopaedics$5K
What the payments were for
- Consulting fees$30,99842%
- Grants$17,14323%
- Travel & lodging$6,4739%
- Food & beverage$5,8308%
- Education$14,00019%
- Entertainment$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 112 | $34,508 |
| Arthrex | 21 | $18,044 |
| Smith+Nephew | 5 | $14,108 |
| Globus Medical | 2 | $7,048 |
| Pacira Pharmaceuticals Incorporated | 1 | $560 |
| Motive Health, Inc. | 1 | $78 |
| RTI Surgical, Inc | 1 | $56 |
| Suvon Surgical LLC | 1 | $42 |
| Overture Orthopaedics | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$74,462 in reported general payments places this provider in the 90th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $7,199 |
| Meloxicam | 331 | $660 |
| Hydromorphone Hcl | 86 | $600 |
| Naproxen | 136 | $573 |
| Ondansetron Hcl | 99 | $565 |
| Dexamethasone | 98 | $337 |
| Tramadol Hcl | 114 | $247 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $94 |
| Omeprazole | 50 | $91 |
| Methylprednisolone | 13 | $77 |
| Ibuprofen | 14 | $49 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Downey
- Bradford HackArcadia$18.3M
- Robert GorabOrange$13.6M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Nirav AminPlacentia$5.6M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
- Peter NewtonSan Diego$4.2M
- Sigurd BervenSan Francisco$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.